100 likes | 113 Views
Explore the latest treatment principles, evidence-based recommendations, and guidelines for weight management drugs, including anorexiants, neurotransmitter reuptake inhibitors, sympathomimetics, and lipase inhibitors. Learn about indications, mechanisms of action, nonpharmacologic and pharmacologic treatments, patient monitoring, and crucial patient education.
E N D
Chapter 70 Weight Management
Drug Overview • Anorexiants • Mixed neurotransmitter reuptake inhibitor • Sympathomimetic • Lipase Inhibitors • Indications
Mechanism of Action • sibutramine • phentermine • orlistat
Treatment Principles • Standardized Guidelines • U.S. Preventive Services Task Force: Guidelines for screening for obesity in adults, revised 2003. • National Heart, Lung, and Blood Institute at NIH: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults, 2003
Treatment Principles • Evidence-Based Recommendations • Cardinal Points of Treatment • Nonpharmacologic Treatment • Diet • Exercise • Behavior • Surgery
Treatment Principles • Pharmacologic Treatment • NHLBI guidelines • Role of diet and exercise • sibutramine • phentermine • orlistat • Herbal and OTC preparations • Evaluation of patients who have taken dexfenfluramine or fenfluramine
Treatment Principles • How to Monitor • Patient Variables • Geriatrics • Pediatrics • Pregnancy and lactation • Patient Education
Anorexiants • sibutramine (Meridia) • Contraindications • Warnings • Precautions • Pharmacokinetics • Adverse effects • Drug interactions • Dosage and administration
Anorexiants • phentermine (Fastin, Ionamin) • Contraindications • Warnings • Precautions • Adverse effects • Dosage and administration
Lipase Inhibitors • orlistat (Xenical, Alli [OTC]) • Contraindications • Warnings • Precautions • Overdosage • Dosage and administration